Immune Systems Advisor

Abstract Background: Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), continues to affect millions globally. Persistent symptoms include fatigue, cognitive impairment, dyspnea, autonomic dysfunction, and multi-organ involvement. Objectives: To summarize the latest 2026 research on biological mechanisms, clinical features, risk factors, and treatment approaches for Long COVID. Methods: Literature review of peer-reviewed publications, government reports, and large cohort studies from 2023–2026, using PubMed, PMC, NIH RECOVER data, and major news outlets reporting verified research. Results: Key mechanisms identified include persistent inflammation, microvascular thrombosis, immune dysregulation, autonomic nervous system involvement, and in some patients, neurodegenerative protein elevations. Reinfection and pre-existing comorbidities are significant risk factors. Current management remains symptom-focused and multidisciplinary. ...

Please enjoy this brief update from the Steve Gruber Show (below) on Real America’s Voice. You may think the claim that twice daily nasal sprays and gargles are better than vaccines is overstated however consider these observations: On demand sporadic Vicks First Defence and Saline nasal sprays reduced the rate of viral upper respiratory tract infection by ~20% as shown in the Immune Defence Study (below). Balmforth et al , demonstrated a 71% risk reduction in COVID-19 illness with a xylitol nasal spray done on a regular basis through the pandemic Influenza vaccine efficacy is running 24-40% in four CDC networks for 2023-2024 COVID-19 vaccine efficacy is negative in four studies, meaning continued vaccination is associated with greater risk of recurrent acute illness. I told Steve Gruber that I have interviewed multiple individuals and have panned my patients. Twice daily ...

For years, clinicians and patients have described a disturbing pattern — cancers appearing suddenly, growing at unexpected speed, or diseases thought stable returning aggressively within weeks or months. A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way. Some called them “turbo cancers”. In oncology, the phenomenon is known as hyper-progression: cancers that accelerate far more rapidly than expected. Early on, these reports were ignored. They surfaced as scattered cases — isolated anecdotes that were easy to dismiss. One of the first to speak publicly was Belgian immunologist Michel Goldman, whose story was published in The Atlantic in 2022. He believed the Covid-19 vaccine may have accelerated his lymphoma. Shortly after vaccination and boosting, he developed swollen lymph nodes, fatigue and night sweats. Imaging revealed ...